| Software Industry | Information Technology Sector | Wayne Douglas Cockburn CEO | OTC PINK Exchange | 09076D101 CUSIP |
| US Country | 5 Employees | - Last Dividend | - Last Split | - IPO Date |
AI Maverick Intel, Inc. is an innovative artificial intelligence company dedicated to acquiring and enhancing various businesses through its proprietary AI Maverick platform. With a strong focus on improving the customer acquisition process, the company automates two-way communication and fosters data-driven engagement with clients’ ideal audience segments. Its applications span several industries, including healthcare and biotechnology, among others. Originally established as Bionoid Pharma Inc. in 2006, the company rebranded to AI Maverick Intel, Inc. in April 2025, signaling a shift towards a tech-driven future. Headquartered in Beverly Hills, California, AI Maverick Intel, Inc. embodies the cutting-edge advancements in AI technology aimed at transforming business operations and client interactions.
This is the core product of AI Maverick Intel, designed to enhance business capabilities through artificial intelligence. The platform automates critical processes such as customer acquisition and engagement, utilizing advanced algorithms to identify and interact with target demographics effectively.
These solutions facilitate seamless two-way communication between businesses and their clients. By leveraging AI, the company offers tools that respond to customer inquiries, reducing response time and enhancing user experience.
AI Maverick provides tools that gather and analyze data to tailor marketing strategies and customer outreach programs. By employing data analytics, the company helps businesses understand their audiences better and engage with them in a more personalized way.
AI Maverick Intel offers customized solutions for various sectors such as healthcare and biotechnology. These applications address the unique challenges in these industries, enhancing operational efficiency and improving customer relationships.